Supplement analysis backed by scientific evidence · PT

← All supplements
Limited evidenceHeart & metabolic

Pata de Vaca

Marketed as 'vegetable insulin,' Bauhinia forficata has one clearly negative trial of the traditional tea and one positive trial of a standardized 300 mg extract. The form matters enormously, and neither result is strong enough to change diabetes management.

What the science says

  • Lowers blood glucose and HbA1c Limited evidence

    The two trials disagree, and the difference is the preparation. A 1990 randomized double-blind crossover in 16 type 2 diabetics and 10 healthy subjects gave an infusion of 3 g of leaves per day for 56 days and found no acute or chronic effect on plasma glucose or glycated hemoglobin — the authors concluded flatly that the infusion has no hypoglycemic effect. A 2022 trial randomized 92 type 2 diabetics to 300 mg of a standardized leaf extract (2% total flavonoids) or placebo alongside their usual oral antidiabetics for 4 months and found significantly lower fasting glucose and HbA1c in the extract group.

  • Improves cholesterol and triglycerides Limited evidence

    A 25-patient quasi-experimental study with no control group had type 2 diabetics drink 0.4% B. forficata tea in 200 mL twice daily for 3 months, reporting drops of 48 mg/dL in triglycerides and 17 mg/dL in total cholesterol. With no randomization, no blinding, and no comparison group, these numbers cannot be separated from the effects of study participation and dietary change.

  • Acts like insulin ('insulina vegetal') Limited evidence

    The nickname is folk branding, not pharmacology. Bauhinia flavonoids such as kaempferitrin have shown glucose-uptake and alpha-amylase-inhibiting activity in cell and docking studies, which is a very different mechanism from insulin. Nothing in the plant substitutes for insulin, and treating it as if it does is dangerous for anyone with type 1 diabetes.

Dosage & safety

Studied doseThe positive trial used 300 mg per day of a standardized dry leaf extract yielding 2% total flavonoids, for 4 months, as an add-on to existing medication. The negative trial used an infusion of 3 g of dried leaves per day for 56 days. If you use it at all, the standardized extract is the only form with supporting data; loose leaf tea has been directly tested and failed.
SafetyNo serious adverse effects were reported in either randomized trial. The realistic risk is additive hypoglycemia when combined with metformin, sulfonylureas, or insulin — monitor glucose if you add it, and never reduce prescribed medication on the strength of a supplement. There is no reproductive safety data, so avoid in pregnancy and breastfeeding, and no long-term data beyond 4 months. Bauhinia is a large genus with many species sold under the same 'cow's hoof' common name, so species verification on the label matters.

Scientific references

Where to buy

View on iHerb

Referral link — this site may earn a commission on purchases.

Related in Heart & metabolic